美股异动 | 终止2期Cevumeran癌症免疫疗法试验 BioNTech(BNTX.US)跌超6%

28 8 月, 2026

One Min Read

1 Views

Last Update: 28 8 月, 2026

Written By

Other Articles

Previous

中远海发(02866)发布中期业绩，股东应占溢利10.01亿元同比增加3.2%

Next

美股异动 | 楼市迎来多项重磅政策贝壳(BEKE.US)高开涨超5.5%

Related Posts

先消灭低价股！

1 Min Read

假期市场思考：A股还是美股？

1 Min Read

香港证券两日成交额破百亿！港股仍有市场？

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept